CorMedix (CRMD) EBITDA Margin (2013 - 2025)
CorMedix (CRMD) reported EBITDA Margin of 45.97% for Q4 2025, up 452.0% on a YoY basis from 8.33% in Q4 2024, and down 6.64% sequentially from 49.24% in Q3 2025.
CorMedix (CRMD) EBITDA Margin (2013 - 2025) Analysis & Trends
CorMedix (CRMD) has 12 years of EBITDA Margin data on file, last reported at 45.97% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin rose 452.0% year-over-year to 45.97%; the trailing twelve-month figure through Dec 2025 stood at 48.17% (up 9956.0% YoY), and the FY2025 full-year result was 48.17%, up 9959.0% from the prior year.
- EBITDA Margin fell to 45.97% in Q4 2025, from 49.24% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 51.5% in Q1 2025 to a low of 102126.07% in Q3 2022.
- A 4-year average of 25279.54% and a median of 8169.54% in 2021 frame the typical range for EBITDA Margin.
- Peak annual rise in EBITDA Margin reached 3304022 bps in 2022, while the deepest fall reached 8392529 bps in 2022.
- Tracing CRMD's EBITDA Margin over 4 years: stood at 13794.92% in 2021, then sank by 105 bps to 28244.66% in 2022, then soared by 100 bps to 41.45% in 2024, then gained by 11 bps to 45.97% in 2025.
- Business Quant data shows CRMD's EBITDA Margin at 45.97% in Q4 2025, 49.24% in Q3 2025, and 49.18% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 472.06 Bn | 467.27 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 122.10 Bn | 114.85 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.25 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 31.68% |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.50 Bn | 959.66 Mn | 23.02% |
| 10 | CorMedix | 4.94 Mn | -150.26 Mn | 107.31 Mn | 45.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.97% |
| Sep 30, 2025 | 49.24% |
| Jun 30, 2025 | 49.18% |
| Mar 31, 2025 | 51.50% |
| Dec 31, 2024 | 41.45% |
| Sep 30, 2024 | -28.70% |
| Jun 30, 2024 | -1,898.09% |
| Dec 31, 2022 | -28,244.66% |
| Sep 30, 2022 | -102,126.07% |
| Jun 30, 2022 | -38,773.09% |
| Mar 31, 2022 | -92,094.83% |
| Dec 31, 2021 | -13,794.92% |
| Sep 30, 2021 | -22,487.18% |
| Jun 30, 2021 | -71,813.31% |
| Mar 31, 2021 | -8,169.54% |
| Dec 31, 2020 | -10,921.20% |
| Sep 30, 2020 | -7,099.29% |
| Jun 30, 2020 | -54,251.71% |
| Mar 31, 2020 | -7,577.91% |
| Dec 31, 2019 | -21,695.96% |